Healthcare Industry News: dBG 300
News Release - March 8, 2011
Heart Force Medical Inc. Appoints Dr. Frank Marcus to Chair Clinical Advisory Board
VANCOUVER, BC, March 8, 2011--(Healthcare Sales & Marketing Network)-- Heart Force Medical Inc., a Vancouver-based company that has developed a non-invasive cardiac assessment, monitoring and screening device is pleased to announce that Dr. Frank Marcus has agreed to chair the recently formed Clinical Advisory Board.Dr. Frank Marcus currently holds the position of Emeritus Professor of Medicine, University of Arizona Sarver Heart Center. Dr. Marcus’ distinguished career includes an appointment as the Chief of Cardiology at the District of Columbia General Hospital Georgetown University Division and Professor of Medicine and Chief of Cardiology at the University Of Arizona College Of Medicine. Dr. Marcus has contributed to over 60 books and published 300 scientific papers. Dr. Marcus has served as an editor of over 10 medical journals and has actively served over 20 medical organizations.
Under Dr. Marcus’ leadership, HFM intends to organize the Clinical Advisory Board to include leading cardiologists that will assist in developing the Company’s clinical program to commercialize its non-invasive cardiac assessment device.
“Having a person of Dr. Marcus’ calibre chair our Clinical Advisory Board will accelerate our ability to commercialize the dBG™ technology,” said Dr. Geoff Houlton, President, CEO and Chief Medical Officer of Heart Force Medical.
“I am pleased that I can help introduce Heart Force’s dBG™ to the cardiology community,” said Dr. Marcus. “I am convinced that the dBG™ technology has the potential to assist physicians across the broad spectrum of standard clinical practice for cardiac assessment and treatment.”
About Heart Force
Heart Force Medical Inc. (HFM), a private company, has invented and holds patents for the digital Ballistocardiograph (dBG™). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). These movements (acceleration and force) are sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM’s proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.
For more information: visit www.heartforcemedical.com or contact:
Geoff Houlton, President and CEO
geoff.houlton@heartforcemedical.com
Direct: 604 566-8202
Issa Nakhleh, CFO
issa.nakhleh@heartforcemedical.com
Direct: 604 566-8206
Source: Heart Force Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!